Top Employee Participation Stories
Biopharma breakthrough year: FDA approved 50% more novel drugs in 2023
By Alan GoforthThe Food and Drug Administration approved 55 new treatments in 2023, representing a nearly 50% increase from the year before, with Pfizer gaining the highest number of high-profile approvals covering a wide range of illnesses.










